BackCollegium Pharmaceutical Overview
Collegium Pharmaceutical Inc

Collegium Pharmaceutical Target Price

See Collegium Pharmaceutical's analyst price targets ($45) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$24.21

Average Target Price

$45.4087.5% upside

5 analysts in the last 4 months

High: $50 | Low: $35

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-06JefferiesGlen Santangelo$3544.6% upsideOpen
2026-09-23Oppenheimer$50106.5% upsideOpen
2026-09-09Truist Financial$49102.4% upsideOpen
2026-09-09Leerink Partners$4585.9% upsideOpen
2026-08-19Barclays$4898.3% upsideOpen
2026-02-10Truist FinancialLes Sulewski$58139.6% upsideOpen
2026-01-09Barclays$56131.3% upsideOpen
2026-01-09H.C. Wainwright$60147.8% upsideOpen
2026-01-07Truist Financial$55127.2% upsideOpen
2025-12-08Barclays$58139.6% upsideOpen
2025-02-04Piper SandlerDavid Amsellem$3648.7% upsideOpen
2024-11-11JefferiesGlen Santangelo$4065.2% upsideOpen
2024-09-04H.C. WainwrightOren Livnat$50106.5% upsideOpen
2024-08-09Piper SandlerDavid Amsellem$3752.8% upsideOpen
2024-07-30H.C. WainwrightOren Livnat$4794.1% upsideOpen
2024-06-07JefferiesGlen Santangelo$4481.7% upsideOpen
2024-05-10Piper SandlerDavid Amsellem$3961.1% upsideOpen
2023-01-05Needham$3544.6% upsideOpen

Collegium Pharmaceutical (COLL) FAQ

Collegium Pharmaceutical (COLL) currently reports a target price of $45. Use the charts on this page to explore Collegium Pharmaceutical's target price history and peer comparisons.

Analysts' average 12-month price target for Collegium Pharmaceutical is $45, about 87.5% upside from the current share price of $24.21. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $45, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Collegium Pharmaceutical, and consider following COLL for alerts when major investors trade the stock.

Collegium Pharmaceutical is classified in the Healthcare sector. On target price, it currently shows $45. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing COLL with unrelated industries.